The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Share News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Redx Pharma Sees Promising Results From Liver Disease Treatment

Tue, 12th Feb 2019 09:45

LONDON (Alliance News) - Redx Pharma PLC said Tuesday that preclinical efficacy data for its ROCK2 compound showed the product was able to have an impact on established fibrosis.

Shares in Redx Pharma were up 11% in morning trading at 7.50 pence each.

The "promising" data from three preclinical animal models of lung, kidney and liver fibrosis showed ROCK2 suppressing collagen deposition and pathways associated with fibrosis. Human studies are planned for 2020.

According to Redx, the data suggest ROCK2 possesses a "suitable pharmacokinetic profile for an orally bioavailable drug". The data also shows the compound has a "low propensity" to inhibit drug enzymes, meaning it is less likely to interact with other drugs.

Redx plans to nominate a drug candidate for ROCK2 by mid-2019. It will be developed as an orally-administered treatment for non-alcoholic steatohepatitis, NASH. The disease is a progressive disease of the liver caused by a build-up of fatty deposits. There are currently no approved treatments for the NASH.

"We are encouraged by the pre-clinical data announced today by Redx. Liver fibrosis associated with NASH remains a condition with a clear unmet medical need and we hope that Redx's research into ROCK2 inhibition progresses into the clinic, potentially producing further data which could lead to a new treatment option for liver fibrosis patients," said Chief Executive Officer Lisa Anson.

More News
1 Jun 2021 15:51

EXECUTIVE CHANGES: Tekmar hires former Kromek CFO; Redx chair departs

EXECUTIVE CHANGES: Tekmar hires former Kromek CFO; Redx chair departs

Read more
1 Jun 2021 15:51

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
19 May 2021 16:24

EXECUTIVE CHANGES: Imperial Brands CFO enters; DF Capital chair exits

EXECUTIVE CHANGES: Imperial Brands CFO enters; DF Capital chair exits

Read more
5 May 2021 16:37

IN BRIEF: Redx Pharma hires New York-based chief financial officer

IN BRIEF: Redx Pharma hires New York-based chief financial officer

Read more
28 Apr 2021 19:19

IN BRIEF: Redx Pharma starts dosing of first patient cohort of RXC004

IN BRIEF: Redx Pharma starts dosing of first patient cohort of RXC004

Read more
2 Mar 2021 21:39

TRADING UPDATES: Chariot expects gas in Morocco; Redx wants CFO in US

TRADING UPDATES: Chariot expects gas in Morocco; Redx wants CFO in US

Read more
23 Feb 2021 16:16

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
27 Jan 2021 14:06

IN BRIEF: Redx Pharma Full-Year Revenue Increases But Loss Widens

IN BRIEF: Redx Pharma Full-Year Revenue Increases But Loss Widens

Read more
20 Jan 2021 16:16

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
23 Dec 2020 15:52

Director dealings: Redx CEO ups stake

(Sharecast News) - Redx Pharma revealed on Wednesday that chief executive Lisa Anson had acquired 39,998 ordinary shares in the AIM-listed drug discovery and development group.

Read more
23 Dec 2020 14:50

UK DIRECTOR DEALINGS SUMMARY: San Leon Energy CEO Cancels Share Buy

UK DIRECTOR DEALINGS SUMMARY: San Leon Energy CEO Cancels Share Buy

Read more
21 Dec 2020 18:10

UK TRADING UPDATE SUMMARY: Novacyt Tests Can Spot New Virus Strain

UK TRADING UPDATE SUMMARY: Novacyt Tests Can Spot New Virus Strain

Read more
2 Dec 2020 17:39

IN BRIEF: Redx Pharma Conditionally Raises GBP25.5 Million Via Placing

IN BRIEF: Redx Pharma Conditionally Raises GBP25.5 Million Via Placing

Read more
27 Oct 2020 15:16

IN BRIEF: Redx Pharma Hires New Chief Medical Officer From Achilles

IN BRIEF: Redx Pharma Hires New Chief Medical Officer From Achilles

Read more
9 Sep 2020 13:33

IN BRIEF: Redx Pharma Teams With Jazz To Develop Cancer Therapies

IN BRIEF: Redx Pharma Teams With Jazz To Develop Cancer Therapies

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.